Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 8, 2015, Pages 1464-1471.e4

  Kapidzic, Atija ^a   van der Meulen, Miriam P ^a   Hol, Lieke ^a   van Roon, Aafke H C ^a   Looman, Caspar W N ^a   Lansdorp Vogelaar, Iris ^a   van Ballegooijen, Marjolein ^a   van Vuuren, Anneke J ^a   Reijerink, Jacqueline C I Y ^b   van Leerdam, Monique E ^a   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Nationwide Screening Organization for the South western Netherlands   (Netherlands)

Author keywords

Colorectal cancer screening; Fecal occult blood test; Immunochemical fecal occult blood test

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED STUDY; FALSE POSITIVE RESULT; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MASS SCREENING; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; CHEMISTRY; COLORECTAL NEOPLASMS; DIAGNOSTIC TEST; FECES; IMMUNOASSAY; LABORATORY TEST; MIDDLE AGED; PROCEDURES;

AGED; CLINICAL LABORATORY TECHNIQUES; COLORECTAL NEOPLASMS; DIAGNOSTIC TESTS, ROUTINE; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 84937509972     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.02.023     Document Type: Article

References (28)

1. Hewitson P., Glasziou P., Irwig L., et al. Screening for colorectal cancer using the faecal occult blood test. Hemoccult. Cochrane Database Syst Rev 2007, 1:CD001216.
2. Allison J.E., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007, 99:1462-1470.
3. Park D.I., et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010, 105:2017-2025.
4. Hol L., et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010, 59:62-68.
5. Imperiale T.F. Noninvasive screening tests for colorectal cancer. Dig Dis 2012, 30(Suppl 2):16-26.
6. Rabeneck L., Rumble R.B., Thompson F., et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol 2012, 26:131-147.
7. Halloran S.P., Launoy G., Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition-faecal occult blood testing. Endoscopy 2012, 44(Suppl 3):SE65-SE87. International Agency for Research on Cancer.
8. von Karsa L., Patnick J., et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013, 45:51-59. European Colorectal Cancer Screening Guidelines Working Group.
9. Kuipers E.J., Rosch T., Bretthauer M. Colorectal cancer screening-optimizing current strategies and new directions. Nat Rev Clin Oncol 2013, 10:130-142.
10. Brenner H., Hoffmeister M., Stegmaier C., et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut 2007, 56:1585-1589.
11. Regula J., Rupinski M., Kraszewska E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 2006, 355:1863-1872.
12. Schoenfeld P., Cash B., Flood A., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005, 352:2061-2068.
13. Lieberman D.A., et al. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001, 345:555-560.
14. Garcia M., et al. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010. J Med Screen 2012, 19:77-82.
15. Steele R.J., et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010, 17:68-74.
16. Weller D., et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007, 97:1601-1605.
17. Steele R.J., et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012, 61:576-581.
18. Brenner H., Haug U., Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010, 105:2457-2464.
19. Stegeman I., et al. Risk factors for false positive and for false negative test results in screening with fecal occult blood testing. Int J Cancer 2013, 133:2408-2414.
20. van Roon A.H., et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 2013, 62:409-415.
21. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. World Health Organization (WHO) 2010.
22. Brenner H., Haug U., Hundt S. Sex differences in performance of fecal occult blood testing. Am J Gastroenterol 2010, 105:2457-2464.
23. Panteris V., Haringsma J., Kuipers E.J. Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy 2009, 41:941-951.
24. Nelson D.B., McQuaid K.R., Bond J.H., et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002, 55:307-314.
25. Lansdorp-Vogelaar I., et al. Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev 2012, 21:728-736.
26. Wilschut J.A., et al. Fecal occult blood testing when colonoscopy capacity is limited. J Natl Cancer Inst 2011, 103:1741-1751.
27. Wilschut J.A., et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology 2011, 141:1648-1655 e1.
28. Stegeman I., et al. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy. Gut 2014, 63:466-471.